Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: results from a retrospective hospital-based cohort study.

Ten Berg MJ, van den Bemt PM, Shantakumar S, Bennett D, Voest EE, Huisman A, van Solinge WW, Egberts TC.

Drug Saf. 2011 Dec 1;34(12):1151-60. doi: 10.2165/11594310-000000000-00000.

PMID:
22077503
[PubMed - indexed for MEDLINE]
2.

Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumors.

Hitron A, Steinke D, Sutphin S, Lawson A, Talbert J, Adams V.

J Oncol Pharm Pract. 2011 Dec;17(4):312-9. doi: 10.1177/1078155210380293. Epub 2010 Sep 7.

PMID:
20823048
[PubMed - indexed for MEDLINE]
3.

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.

Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L.

Clin Ther. 2009;31 Pt 2:2416-32. doi: 10.1016/j.clinthera.2009.11.020.

PMID:
20110050
[PubMed - indexed for MEDLINE]
4.

Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.

ten Berg MJ, van den Bemt PM, Huisman A, Schobben AF, Egberts TC, van Solinge WW.

Ann Pharmacother. 2009 Sep;43(9):1405-12. doi: 10.1345/aph.1L646. Epub 2009 Aug 18.

PMID:
19690229
[PubMed - indexed for MEDLINE]
5.

Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.

Rajkumar SV, Frytak S, Rubin J, Camoriano JK, Fitch TR.

Am J Clin Oncol. 1997 Oct;20(5):500-4.

PMID:
9345336
[PubMed - indexed for MEDLINE]
6.

Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.

Niwa T, Suzuki A, Sakakibara S, Kasahara S, Yasuda M, Fukao A, Matsuura K, Goto C, Murakami N, Itoh Y.

Clin Ther. 2009 Oct;31(10):2126-33. doi: 10.1016/j.clinthera.2009.10.017.

PMID:
19922883
[PubMed - indexed for MEDLINE]
7.

Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia.

Levin RD, Daehler M, Grutsch JF, Hall JL, Gupta D, Lis CG.

BMC Cancer. 2010 Oct 19;10:565. doi: 10.1186/1471-2407-10-565.

PMID:
20955619
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.

Cairo MS, Davenport V, Bessmertny O, Goldman SC, Berg SL, Kreissman SG, Laver J, Shen V, Secola R, van de Ven C, Reaman GH.

Br J Haematol. 2005 Jan;128(1):49-58.

PMID:
15606549
[PubMed - indexed for MEDLINE]
9.

Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.

Donato BM, Burns L, Willey V, Cohenuram M, Oliveria S, Yood MU.

Clin Ther. 2010 Mar;32(3):546-54. doi: 10.1016/j.clinthera.2010.03.007.

PMID:
20399992
[PubMed - indexed for MEDLINE]
10.

Recent strategies for the use of paclitaxel in the treatment of urological malignancies.

Bokemeyer C, Hartmann JT, Kuczyk MA, Truss MC, Kollmannsberger C, Beyer J, Jonas U, Kanz L.

World J Urol. 1998;16(2):155-62. Review.

PMID:
12073232
[PubMed - indexed for MEDLINE]
11.

Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.

Chang AY, Boros L, Garrow GC, Asbury RF, Hui L.

Semin Oncol. 1996 Jun;23(3 Suppl 6):74-7.

PMID:
8677454
[PubMed - indexed for MEDLINE]
12.

Hematological side-effect profiles of individualized chemotherapy regimen for recurrent ovarian cancer.

Breidenbach M, Rein DT, Schöndorf T, Schmidt T, König E, Valter M, Kurbacher CM.

Anticancer Drugs. 2003 Jun;14(5):341-6.

PMID:
12782939
[PubMed - indexed for MEDLINE]
13.

[A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].

Bai CM, Xu GX, Zhao YQ, Han SM, Shan YD.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Aug;26(4):437-41. Chinese.

PMID:
15379272
[PubMed - indexed for MEDLINE]
14.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
[PubMed - indexed for MEDLINE]
15.

[Clinical study of rhIL-11 for prevention and treatment of chemotherapy-induced thrombocytopenia].

Sun XF, Guan ZZ, Huang H, Zhou QH, Yi C, Zhang LJ, Zhu J, Li R, Zhou J, Zhang M, Guo Y.

Ai Zheng. 2002 Aug;21(8):892-5. Chinese.

PMID:
12478901
[PubMed - indexed for MEDLINE]
16.

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.

Holloway RW, Mehta RS, Finkler NJ, Li KT, McLaren CE, Parker RJ, Fruehauf JP.

Gynecol Oncol. 2002 Oct;87(1):8-16.

PMID:
12468336
[PubMed - indexed for MEDLINE]
17.

Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers.

Markman M, Markman J, Webster K, Zanotti K, Kulp B, Peterson G, Belinson J.

J Cancer Res Clin Oncol. 2004 Dec;130(12):741-4. Epub 2004 Aug 27.

PMID:
15338296
[PubMed - indexed for MEDLINE]
18.

Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study.

Weycker D, Malin J, Kim J, Barron R, Edelsberg J, Kartashov A, Oster G.

Clin Ther. 2009 May;31(5):1069-81. doi: 10.1016/j.clinthera.2009.05.019.

PMID:
19539108
[PubMed - indexed for MEDLINE]
19.

Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.

Vadhan-Raj S, Verschraegen CF, Bueso-Ramos C, Broxmeyer HE, Kudelkà AP, Freedman RS, Edwards CL, Gershenson D, Jones D, Ashby M, Kavanagh JJ.

Ann Intern Med. 2000 Mar 7;132(5):364-8.

PMID:
10691586
[PubMed - indexed for MEDLINE]
20.

Incidence of second cancers in patients treated for Hodgkin's disease.

Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P, et al.

J Natl Cancer Inst. 1995 May 17;87(10):732-41.

PMID:
7563150
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk